AstraZeneca warns of higher costs as drug sales slide

jeudi 1 août 2013

By Ben Hirschler LONDON (Reuters) - British drugmaker AstraZeneca (LSE:AZN) warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expires on key medicines. ...



via Business News http://finance.yahoo.com/news/astrazeneca-warns-higher-costs-drug-084417364.html

0 commentaires:

Enregistrer un commentaire